The Company is expanding a personalized medicine method for activating the cellular arm of immunity that enhances identification of pathogens and infected cell antigens. This induced pathway clears the host of viral, bacterial, fungal infections and cancer cells. The Company also has developed superior wound healing technology for the undrserved hospital and retail burn, tissue repair and wound care markets. Primate trials next. Visit website.